Compound ID | 1958

Update compound information

Durlobactam

Synonym(s): ETX-2514  |  ETX2514

Class: Beta-lactam + beta-lactamase inhibitor

Agent Type: Synthetic; Small molecule; Direct acting; Antibiotic adjuvant;
Mechanism of action: Cell wall synthesis inhibitor. Binds reversibly to the beta-lactamase in the active site, inhibits class A, C, D and weakly inhibits penicillin binding protein 2 in Enterobacteriaceae
Combined with other compounds: Yes
Description: Synthetic compound. In clinical development in fixed combination with Sulbactam against Acinetobacter infections.
Institute where first reported: Entasis Therapeutics, Innoviva
Year first mentioned: 2017
Highest development stage: Phase 3 (NCT03894046)
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 277.26
Iso. SMILES: CC1=C[C@@H]2CN([C@@H]1C(=O)N)C(=O)N2OS(=O)(=O)O
InChI Key: BISPBXFUKNXOQY-RITPCOANSA-N
Can. SMILES: CC1=C[C@@H]2CN([C@@H]1C(=O)N)C(=O)N2OS(=O)(=O)O
InChI: InChI=1S/C8H11N3O6S/c1-4-2-5-3-10(6(4)7(9)12)8(13)11(5)17-18(14,15)16/h2,5-6H,3H2,1H3,(H2,9,12)(H,14,15,16)/t5-,6+/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/89851852
Guide to Pharmacology: durlobactam
Citation: https://pubmed.ncbi.nlm.nih.gov/28835096/

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.